[Table/Fig-3]:
Drug Group | Maculo-papular rash (%) | Urticaria (%) |
SJS (%) | FDE (%) | Pustular rash (%) |
Angiodema (%) |
Exfoliative Dermatitis (%) | Overall (%) |
---|---|---|---|---|---|---|---|---|
Antiretroviral | 53(58.89) | 07(07.78) | 04(04.44) | - | 02(02.22) | 02(02.22) | - | 68(75.56) |
Antibacterial | 08(08.89) | - | - | - | - | - | 01(01.11) | 09(10) |
Antiepileptic | 03(03.33) | - | - | 02(02.22) | - | - | 01(01.11) | 06(06.67) |
NSAIDs | 02(02.22) | 01(01.11) | - | 01(01.11) | - | - | - | 04(04.44) |
Antihistaminics | 01(01.11) | - | - | - | - | - | - | 01(01.11) |
Others | 02(02.22) | - | - | - | - | - | - | 02(02.22) |